Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients

समान संसाधन

• Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients
  द्वारा: Boudewijns, Steve, और अन्य
  प्रकाशित: (2016)
• Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
  द्वारा: Bol, Kalijn F, और अन्य
  प्रकाशित: (2015)
• Dendritic cell vaccination and immune monitoring
  द्वारा: Aarntzen, E. H. J. G., और अन्य
  प्रकाशित: (2008)
• Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
  द्वारा: Bol, Kalijn, और अन्य
  प्रकाशित: (2015)
• Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4(+) T cells after FcγRII-mediated uptake
  द्वारा: Benitez-Ribas, Daniel, और अन्य
  प्रकाशित: (2006)